Research on Non-Melanoma Skin Cancer and Kidney Transplant Failure

Understanding Non-Melanoma Skin Cancer (NMSC)

Non-melanoma skin cancer (NMSC) encompasses various types of skin cancer excluding melanoma. This form of cancer is frequently observed in patients who have experienced kidney transplant failure, particularly during dialysis treatment.

Study Objectives

Researchers, led by Sexton and colleagues, aimed to investigate the relationship between kidney transplants and the risk of developing NMSC. They specifically focused on individuals who faced kidney transplant failure and subsequently required dialysis, seeking to determine if their risk of NMSC differed from that of patients with successful transplants. The findings of this study were published in JAMA Dermatology.

Data Collection and Analysis

The researchers utilized data from The Irish National Kidney Transplant Service database and the Irish National Cancer Registry, covering the period from 1994 to 2014. Their analysis was completed by December 31, 2015.

Findings on Kidney Transplant Failure and NMSC

From the databases, a total of 3,821 participants who underwent one, two, or three kidney transplants were identified. The overall rate of NMSC was found to be 39.69 per 1,000 patient-years. Notably, patients who underwent dialysis following kidney transplant failure exhibited a lower incidence of NMSC.

Potential Risk Factors

The authors identified several potential risk factors for NMSC, including age, male gender, and the number of transplants received. They also highlighted that certain immunosuppressant medications, such as tacrolimus, may be associated with a reduced risk of NMSC compared to cyclosporin.

Conclusion and Implications

The study concluded that there are differences in NMSC rates between individuals with functioning kidney transplants and those on dialysis. A significant strength of the research is its ability to analyze multiple data points from the same individual, particularly during periods of dialysis while waiting for subsequent transplants.

Impact of Immunosuppressants on NMSC Rates

The authors suggested that immunosuppressants might influence NMSC rates, even after their administration has ceased. Additionally, longer follow-up periods could further impact the observed NMSC rates among those using specific immunosuppressive drugs.

Limitations of the Study

Several limitations should be noted. The study’s design limits the ability to draw definitive conclusions. Furthermore, the prevalence of skin cancer cases may be higher than expected due to increased surveillance in clinics specializing in kidney treatment. Various biases could also influence the findings. Nonetheless, this study significantly contributes to the existing literature on NMSC in the context of kidney transplantation.

Reference

Sexton DJ et al. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants. JAMA Dermatology. 2019; E1-E5. doi:10.1001/jamadermatol.2018.4660